Patterns of First Relapse and Outcome in Patients with Locally Advanced Cervical Cancer After Radiochemotherapy: A Single Institutional Experience
Autor: | Ajay Sasidharan, Umesh M. Mahantshetty, Lavanya Gurram, Supriya Chopra, Reena Engineer, Amita Maheshwari, Sudeep Gupta, Kedar Deodhar, Venkatesh Rangarajan, Meenakshi Thakur, Shyam Kishore Shrivastava |
---|---|
Rok vydání: | 2019 |
Předmět: |
Cervical cancer
medicine.medical_specialty Chemotherapy 030219 obstetrics & reproductive medicine Palliative care business.industry medicine.medical_treatment Standard treatment Brachytherapy Obstetrics and Gynecology medicine.disease Surgery Radiation therapy 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Oncology Surgical oncology 030220 oncology & carcinogenesis Medicine business Cervix |
Zdroj: | Indian Journal of Gynecologic Oncology. 18 |
ISSN: | 2363-8400 2363-8397 |
DOI: | 10.1007/s40944-019-0345-7 |
Popis: | Radiochemotherapy followed by brachytherapy is the standard treatment in locally advanced cervical cancer. The aim of this study was to evaluate the patterns of first relapse, the treatment given and its outcome. This is a retrospective analysis of electronic records of locally advanced cervical cancer patients treated in prospective trials from 2003 to 2014. Out of 1388 patients, relapse was seen in 316 (23%). Relapse was seen as—pelvic: 105 (7.6%), distant: 136 (10%), and both: 75 (5.4%). Local, regional, paraaortic and systemic relapses were seen in 148 (10.8%), 65 (4.7%), 102 (7.4%) and 163 (11.8%) patients, respectively. Post-relapse, 201/316 (63.6%) received palliative care alone. Treatment in the form of concurrent or sequential chemo-radiotherapy, surgery, stereotactic body radiotherapy and reirradiation using brachytherapy was received by 15 (4.7%), 7 (2.2%), 1 (0.3%) and 1(0.3%) patients, respectively; 65 (20.6%) received palliative chemotherapy, and 28 (8.9%) received palliative radiotherapy. Median post-relapse survival was 7 months (95% CI 5.9–8.1); and in those who received treatment versus supportive care was 10 (95% CI 7.0–13.0) versus 5 (95% CI 3.9–6.1) months (p 1-year post-relapse survival was 85.7% in surgery, 66.7% in concurrent or sequential chemotherapy plus radiation, 32.3% in palliative chemotherapy, 14.3% in palliative radiotherapy and 13.4% in supportive care. Distant failure is the predominant pattern of relapse seen in patients undergoing radiochemotherapy for locally advanced cervical cancer. Well-selected single-site relapses treated with surgery or chemotherapy plus radiation can have good post-relapse survival. |
Databáze: | OpenAIRE |
Externí odkaz: |